Page last updated: 2024-10-27

fenofibrate and Cancer of Mouth

fenofibrate has been researched along with Cancer of Mouth in 4 studies

Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE

Research Excerpts

ExcerptRelevanceReference
"Fenofibrate is a clinical lipid-lowering agent and an effective anticancer drug."1.43Fenofibrate Suppresses Oral Tumorigenesis via Reprogramming Metabolic Processes: Potential Drug Repurposing for Oral Cancer. ( Chang, NW; Chiu, CF; Huang, YP; Jan, CI; Liu, CJ; Tsai, MH, 2016)
"0."1.37Fenofibrate exhibits a high potential to suppress the formation of squamous cell carcinoma in an oral-specific 4-nitroquinoline 1-oxide/arecoline mouse model. ( Chang, NW; Chiu, CF; Chu, PY; Hsu, HT; Lin, C; Tsai, MH; Yeh, CM; Yeh, KT, 2011)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Su, TR1
Yu, CC1
Chao, SC1
Huang, CC1
Liao, YW1
Hsieh, PL1
Yu, CH1
Lin, SS1
Tsai, SC1
Tsai, MH3
Chiu, CF3
Lu, CC1
Kuo, SC1
Chang, NW3
Yang, JS1
Jan, CI1
Huang, YP1
Liu, CJ1
Lin, C1
Hsu, HT1
Chu, PY1
Yeh, CM1
Yeh, KT1

Other Studies

4 other studies available for fenofibrate and Cancer of Mouth

ArticleYear
Fenofibrate diminishes the self-renewal and metastasis potentials of oral carcinoma stem cells through NF-κB signaling.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2022, Volume: 121, Issue:10

    Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Fenofibrat

2022
AMPK-dependent signaling modulates the suppression of invasion and migration by fenofibrate in CAL 27 oral cancer cells through NF-κB pathway.
    Environmental toxicology, 2016, Volume: 31, Issue:7

    Topics: AMP-Activated Protein Kinases; Cell Line, Tumor; Cell Movement; Fenofibrate; Humans; Hypolipidemic A

2016
Fenofibrate Suppresses Oral Tumorigenesis via Reprogramming Metabolic Processes: Potential Drug Repurposing for Oral Cancer.
    International journal of biological sciences, 2016, Volume: 12, Issue:7

    Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Pr

2016
Fenofibrate exhibits a high potential to suppress the formation of squamous cell carcinoma in an oral-specific 4-nitroquinoline 1-oxide/arecoline mouse model.
    Biochimica et biophysica acta, 2011, Volume: 1812, Issue:4

    Topics: 4-Nitroquinoline-1-oxide; Acetyl-CoA Carboxylase; Animals; Anticarcinogenic Agents; Arecoline; Carci

2011